Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-18-010536)

Filing Details

Accession Number:: 0001209191-18-010536
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2018-02-15 19:31:32
Reporting Period:: 2018-02-12

Accepted Time:: 2018-02-15 19:31:32
Original Submission Date:: 2018-02-14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1594864	Juno Therapeutics Inc.	JUNO	Biological Products, (No Disgnostic Substances) (2836)	463656275

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1656998	Robert Azelby	C/O 400 Dexter Avenue North Suite 1200 Seattle WA 98109	Evp & Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2018-02-12	4,159	$85.55	89,612	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 20, 2017.
This Amendment to Form 4 is filed solely for the purpose of correcting a clerical error in the number of shares sold, as reported on the Form 4 filed February 14, 2018.